Identification of Genes Associated With Lung Disease in Patients With Rheumatoid Arthritis
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00001885|
Recruitment Status : Completed
First Posted : November 4, 1999
Last Update Posted : July 2, 2017
Pulmonary fibrosis (PF) is a condition in which the lungs of a patient become scarred and fibrous. It has been known to occur in as many as 40% of patients diagnosed with rheumatoid arthritis (RA). The cause of the pulmonary fibrosis in patients with RA is unknown.
Data gathered from previous research studies suggest that genetics may play a role in the development of PF in patients with rheumatoid arthritis. However, the actual genetic factors involved in the disease process have not been identified.
The goal of this study is to identify the genetic markers in patients with pulmonary fibrosis and rheumatoid arthritis.
|Condition or disease|
|Healthy Pulmonary Fibrosis Rheumatoid Arthritis|
|Study Type :||Observational|
|Enrollment :||400 participants|
|Official Title:||Pulmonary Fibrosis Associated With Rheumatoid Arthritis: Identification of Genetic Polymorphisms|
|Study Start Date :||March 21, 1999|
|Study Completion Date :||December 28, 2007|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00001885
|United States, Maryland|
|National Institutes of Health Clinical Center, 9000 Rockville Pike|
|Bethesda, Maryland, United States, 20892|